Advanced Non-Small Cell Squamous Lung Cancer
6 clinical trials · Condition
◉ Watch Advanced Non-Small Cell Squamous Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations (NCT05256290) | Black Diamond Therapeutics, Inc. | 2022-03-31 |
| Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC (NCT04846452) | The First Affiliated Hospital with Nanjing Medical University | 2021-06-01 |
Track Advanced Non-Small Cell Squamous Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.